drugset / Trial / NCT04219865
Safety, Tolerance and Pharmacokinetics Study of Compound Edaravone Injection
RandomizedFactorialTriple-blindBasic science
Summary
Study on the Safety, Tolerance and Pharmacokinetics of Single-dose, Increasing and Loading Dose and Maintenance Dose Sequential Intravenous Infusion of Compound Edaravone Injection in Chinese Healthy Volunteers
Timeline
- Start
- 2019-06-05
- Primary completion
- 2019-08-16
- Completion
- 2019-08-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | 2-Aminoethanesulfonic Acid | Unknown | 600 mg | Intravenous |
| Comparator | 2-Aminoethanesulfonic Acid | Unknown | 1200 mg | Intravenous |
| Comparator | 2-Aminoethanesulfonic Acid | Unknown | 1800 mg | Intravenous |
| Comparator | 2-Aminoethanesulfonic Acid | Unknown | 2400 mg | Intravenous |
| Comparator | Edaravone | Unknown | 30 mg | Intravenous |
| Comparator | Edaravone | Unknown | 60 mg | Intravenous |
| Comparator | Edaravone | Unknown | 90 mg | Intravenous |
| Comparator | Edaravone | Unknown | 120 mg | Intravenous |
Indications
No indication recorded.